Awards/COOPERATIVE AGREEMENT (B)

$293,973,011

Department of Health and Human Services·Centers for Disease Control and Prevention

ACTION DATE2026-04-06·SOURCEUSASPENDING·SOURCE IDASST_NON_NU50CK000519_075

Award description

RHODE ISLAND EPIDEMIOLOGY AND LABORATORY CAPACITY FOR PREVENTION AND CONTROL OF EMERGING INFECTIOUS DISEASES (ELC)

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Funds Rhode Island's epidemiology and laboratory capacity to detect, prevent, and control emerging infectious diseases.

Sub-sectors

infectious-disease-surveillancepublic-health-infrastructureepidemiology

Why this matters

Strengthens domestic disease surveillance and response infrastructure critical for pandemic preparedness and public health resilience.

Supply-chain signal

Increases demand for diagnostic equipment, laboratory reagents, and bioinformatics systems from suppliers supporting state health departments.

U.S.–China competition angle

Reduces U.S. dependence on foreign diagnostic capabilities and builds domestic biodefense capacity against emerging pathogens.

Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-14. Cost: $0.001372.

Period of performance

Start

2019-08-01

End

2027-07-31

Status

activein 442 days

Sources

Award record ingested from usaspending. Source identifier ASST_NON_NU50CK000519_075.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.